CJC-1295 (No DAC) and Ipamorelin are often studied together for their synergistic effects on stimulating growth hormone release. CJC-1295 acts as a GHRH analog, while Ipamorelin functions as a ghrelin receptor agonist together, they promote pulsatile GH secretion in laboratory studies. Research focuses on their potential impact on metabolism, recovery, and endocrine regulation.
